Navigation Links
Avanir Pharmaceuticals to Participate in Two Conferences in March
Date:3/1/2012

ALISO VIEJO, Calif., March 1, 2012 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that company management will participate in the following conferences in March.

  • Cowen & Company Healthcare Conference
    • Location: Boston Marriott, Boston , MA
    • Date: Tuesday March 6, 2012
    • Presentation time: 8:00 a.m. ET

  • 2012 Roth OC Growth Conference
    • Location: The Ritz Carlton, Laguna Niguel, CA
    • Date: Tuesday March 13, 2012
    • Presentation time: 4:30 p.m. PT

A live webcast and 30-day archive of these presentations will be available at http://ir.avanir.com.

About Avanir Pharmaceuticals, Inc.

Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit www.avanir.com.

AVANIR® is a registered trademark owned by Avanir Pharmaceuticals, Inc.

© 2012 Avanir Pharmaceuticals, Inc. All Rights Reserved.

Avanir Investor & Media Contact
Ian Clements, PhD
ir@avanir.com
+1 (949) 389-6700


'/>"/>
SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Avanir Pharmaceuticals and Concert Pharmaceuticals Announce License Agreement to Develop and Commercialize Deuterium-modified Dextromethorphan for Disorders of the Nervous System
2. Avanir Pharmaceuticals Announces Publication of Phase III Study Results Showing Efficacy and Safety of AVP-923 in the Treatment of Diabetic Neuropathic Pain
3. Avanir Pharmaceuticals Reports Fiscal 2011 Fourth Quarter and Year End Financial Results
4. Avanir Pharmaceuticals Announces Date of Fiscal 2011 Fourth Quarter and Year End Financial Results and Conference Call
5. Avanir Pharmaceuticals to Participate in Piper Jaffray Health Care Conference
6. Avanir Pharmaceuticals Announces EMA Acceptance of Marketing Authorization Application for NUEDEXTA
7. Avanir Pharmaceuticals Submits European Marketing Authorization Application for NUEDEXTA
8. Avanir Pharmaceuticals to Present Data at the 2011 American Congress of Rehabilitation Medicine/American Society for Neurorehabilitation Medicine Annual Conference
9. Avanir Pharmaceuticals to Participate in Two Investor Conferences
10. Avanir Pharmaceuticals to Present at Stifel Nicolaus Healthcare Conference
11. Avanir Pharmaceuticals Files Lawsuits Against Par and Actavis for Infringement of NUEDEXTA Patents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... Research and Markets has announced the addition of the ... - Forecast to 2025" report to their offering. ... The Global Implantable Medical ... 5.4% over the next decade to reach approximately $54.28 billion by ... is witnessing include 3D medical printing is expected to develop and ...
(Date:1/24/2017)... GAITHERSBURG, Md. , Jan. 24, 2017 /PRNewswire/ ... leader in the engineering and industrialization of biology to improve ... announced that it has entered into a definitive agreement to ... a clinical-stage company and pioneer in the development of AdenoVerse™ ... and expand upon GenVec,s expertise in adenoviral vectors and cGMP ...
(Date:1/24/2017)... 24, 2017   QR Pharma , Inc., ... novel therapies for the treatment of Alzheimer,s, Parkinson,s ... of four world-class key opinion leaders to its ... QR Pharma,s previous roster of impressive advisors in ... support the development of the breakthrough mechanism of ...
Breaking Medicine Technology:
(Date:1/24/2017)... ... 2017 , ... The Cruise Web Inc. was recognized today as ... Annual MSC True Partnerships’ Awards. , The 2016 MSC True Partnerships Awards ... based on overall business growth in revenue and guests and continuous partnership support and ...
(Date:1/24/2017)... ... January 24, 2017 , ... West’s ... its annual Solutions Series of webinars will start January 31 with a session ... number of current health and benefits topics, including employee engagement, pricing transparency, population ...
(Date:1/24/2017)... (PRWEB) , ... January 24, 2017 , ... Center ... 21st century leadership, has named Hector M. Chavez, Manager, Employee & Labor Relations at ... center - as its Hispanic Leader of the Month. City of Hope is committed ...
(Date:1/24/2017)... (PRWEB) , ... January 24, 2017 , ... ... Really Need to Thrive , Well-meaning studies such as the Fordham Institute’s ... can better serve top students, such as including gifted or high-achieving students as ...
(Date:1/24/2017)... MA (PRWEB) , ... January 24, 2017 , ... American ... in Bedford, expanding access to high-quality health care for residents in the area. The ... fourth location opened during the past four years by Dave Adams and Dr. Kristina ...
Breaking Medicine News(10 mins):